Improving prevention strategies for cardiometabolic disease. (2020)
Attributed to:
Stat2 is a therapeutic target in liver inflammation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-020-0786-7
PubMed Identifier: 32152584
Publication URI: http://europepmc.org/abstract/MED/32152584
Type: Journal Article/Review
Volume: 26
Parent Publication: Nature medicine
Issue: 3
ISSN: 1078-8956